Eton Pharmaceuticals Stock Analysis

Eton Stock Analysis Notes

About 53.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.18. Eton Pharmaceuticals had not issued any dividends in recent years. Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois. Eton Pharmaceutcials operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people. To learn more about Eton Pharmaceuticals call Sean Brynjelsen at 847 787 7361 or check out https://www.etonpharma.com.

Eton Pharmaceuticals Investment Alerts

Eton Pharmaceuticals Upcoming and Recent Events

Eton Largest EPS Surprises

View All Earnings Estimates

Eton Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Eton Stock Institutional Investors

Note, although Eton Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Eton Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 402.8 M.

Eton Profitablity

The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03.

Management Efficiency

Eton Pharmaceuticals has return on total asset (ROA) of (0.0202) % which means that it has lost $0.0202 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2295) %, meaning that it created substantial loss on money invested by shareholders. Eton Pharmaceuticals' management efficiency ratios could be used to measure how well Eton Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of July 2025, Return On Tangible Assets is likely to drop to -0.1. In addition to that, Return On Capital Employed is likely to drop to -0.05. At this time, Eton Pharmaceuticals' Total Assets are very stable compared to the past year. As of the 20th of July 2025, Net Tangible Assets is likely to grow to about 12.2 M, while Non Currrent Assets Other are likely to drop about 10.3 K.

Technical Drivers

As of the 20th of July, Eton Pharmaceuticals shows the Downside Deviation of 3.14, mean deviation of 2.42, and Coefficient Of Variation of 1803.56. Eton Pharmaceuticals technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Eton Pharmaceuticals Price Movement Analysis

Eton Pharmaceuticals Insider Trading Activities

Eton Pharmaceuticals Outstanding Bonds

Eton Pharmaceuticals Predictive Daily Indicators

Eton Pharmaceuticals Corporate Filings

Eton Pharmaceuticals Forecast Models

Eton Pharmaceuticals' time-series forecasting models are one of many Eton Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Eton Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Eton Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eton shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Eton Pharmaceuticals. By using and applying Eton Stock analysis, traders can create a robust methodology for identifying Eton entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Eton analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Eton analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Eton Pharmaceuticals stock analysis indicators help investors evaluate how Eton Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Eton Pharmaceuticals shares will generate the highest return on investment. By understating and applying Eton Pharmaceuticals stock analysis, traders can identify Eton Pharmaceuticals position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eton Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.